Source: Annual Congress 2005 - Burden and management of obstructive airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. J. Mortimer, L. J. Tata, C. J. Smith, J. West, T. W. Harrison, A. E. Tattersfield, R. B. Hubbard (Nottingham, United Kingdom). Inhaled corticosteroids and adrenal insufficiency: a case-control study. Eur Respir J 2005; 26: Suppl. 49, 1420

Member's Comments

No comment yet.

Related content which might interest you: The use of inhaled corticosteroids and the risk of adrenal insufficiency Source: Eur Respir J 2013; 42: 79-86 Year: 2013 Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids Source: Eur Respir J 2008; 32: 1047-1052 Year: 2008 Inhaled corticosteroids in COPD: the case against Source: Eur Respir J 2009; 34: 13-16 Year: 2009 Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis Source: Eur Respir J 2006; 28: 960-967 Year: 2006 Inhaled corticosteroids use in patients with bronchiectasis: Data from the EMBARC registry Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021 Getting risks right on inhaled corticosteroids and adrenal insufficiency Source: Eur Respir J 2013; 42: 9-11 Year: 2013 Inhaled corticosteroid therapy and risk of hospitalization with pneumonia: a population-based case-control study from Denmark Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study Source: Eur Respir J, 53 (6) 1801257; 10.1183/13993003.01257-2018 Year: 2019 Inhaled steroids doses to obtain asthma control in children: a randomised concurrent cohort study Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009 Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004 Low risk of adrenal dysfunction in children with severe asthma treated with high-dose inhaled glucocorticoids Source: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005 Inhaled corticosteroids in COPD: a case in favour Source: Eur Respir J 2009; 34: 10-12 Year: 2009 Inhaled corticosteroids in asthma and longitudinal change in lung function: a systematic review and meta-analysis Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Adrenal crisis and hypercorticism induced by inhaled corticosteroids Source: Eur Respir J 2006; 28: Suppl. 50, 665s Year: 2006 Inhaled steroids in children: adrenal suppression and growth impairment Source: Eur Respir J 2002; 19: 985-988 Year: 2002 Inhaled steroids and prevalence of osteoporosis in chronic obstructive pulmonary disease: Data from the DACCORD cohort Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Adrenal insufficiency in asthma treated with high/low systemic corticosteroids in the past and in those who sucessfully discontinued systemic corticosteroids after treatment with omalizmab. Source: International Congress 2017 – Management of asthma in different situations Year: 2017 Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results Source: Eur Respir J 2009; 34: 641 Year: 2009 Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Concomitant corticosteroid with anti-fibrotic therapy for idiopathic pulmonary fibrosis: a prospective multicenter study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021